Mirjam Kobler, PhD, is currently Global Business Development Manager for H&T Presspart. Dr Kobler oversees the management and business development activities for H&T Presspart’s DPI device portfolio. Before joining H&T Presspart Dr Kobler worked at Meggle, where she headed the R&D Department of Meggle’s Excipients and Technology business group. Dr Kobler’s background includes seven years of experience in various areas of lactose excipients, especially for DPIs.
Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.